how-xermelo-helps

XERMELO™ further reduces carcinoid syndrome diarrhea

89% of patients saw improvement of any level in carcinoid syndrome diarrhea while taking XERMELO™ with somatostatin analog (SSA) injections

People who continued to take XERMELO™ with SSA injections for 12 weeks had a reduction in bowel movements. People who continued to take XERMELO™ with SSA injections for 12 weeks had a reduction in bowel movements.

It’s important to keep taking XERMELO™ every day to treat carcinoid syndrome diarrhea.

About the Study

In a clinical study, patients with carcinoid syndrome diarrhea received XERMELO™ in addition to SSA injections. They were followed for 12 weeks, and observed for reductions in daily bowel movements.

Remember to talk to your doctor to see if XERMELO™ may be right for you.

See how XERMELO™ can fit into your everyday schedule
Learn more

Social Image

Important Safety Information and Indication

Important Safety Information

  • XERMELO may cause constipation which can be serious. You should stop taking XERMELO if severe constipation or severe, persistent, or worsening abdominal pain develops
  • The most common side effects of XERMELO include nausea, headache, increase in hepatic enzymes, depression, flatulence, decreased appetite, swelling of your hands and feet, and fever

Indication

XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy.

For more information about XERMELO, talk to your doctor or see Full Prescribing Information.